 |
|
Association of Novel POLG Mutations and Multiple Mitochondrial DNA Deletions With Variable Clinical Phenotypes in a Spanish Population
Emiliano González-Vioque, BSc;
Alberto Blázquez, BSc;
Daniel Fernández-Moreira, PharmB;
Belén Bornstein, MD, PhD;
Juan Bautista, MD;
Javier Arpa, MD;
Carmen Navarro, MD, PhD;
Yolanda Campos, PhD;
Miguel A. Fernández-Moreno, PhD;
Rafael Garesse, PhD;
Joaquin Arenas, PhD;
Miguel A. Martín, PhD
Arch Neurol. 2006;63:107-111.
Background Both dominant and recessive mutations were reported in the gene encoding the mitochondrial (mt) DNA polymerase  (POLG) in patients with progressive external ophthalmoplegia (PEO). Phenotypes other than PEO were recently documented in patients with mutations in the POLG gene.
Objective To screen patients with mitochondrial disease and multiple mtDNA deletions in muscle for mutations in the coding regions of the POLG, PEO1, and SLC25A4 genes.
Design To identify the underlying molecular defect in a group of patients with multiple mtDNA deletions comparing their molecular genetic findings with those of healthy controls.
Patients Twenty-four patients (16 men and 8 women) diagnosed with mitochondrial disease and having multiple mtDNA deletions in muscle by Southern blot analysis. Thirteen patients had PEO; 2 had PEO alone, 4 had PEO and myopathy, and 5 had PEO and multisystem involvement. Four patients had multisystem disease without PEO. The remaining 9 patients had isolated myopathy. DNA from 100 healthy individuals was also studied.
Results No mutation was identified in the PEO1 or SLC25A4 genes. Nine POLG mutations were observed in 6 of 24 patients. Four novel mutations were detected and mapped in the linker region (M603L) and in the pol domain of the enzyme (R853W; D1184N; R1146C). Five patients with PEO had mutations: 2 were compound heterozygotes, 1 was homozygous, and another showed a mutation in a single allele. The remaining patient also showed a sole mutation and had an unusual phenotype lacking ocular involvement.
Conclusions POLG molecular defects were found in 25% of our patients with multiple mtDNA deletions and mitochondrial disease. The uncommon phenotype found in 1 of these patients stresses the clinical variability of patients harboring POLG mutations. Molecular studies in the POLG gene should be addressed in patients with mitochondrial disease, particularly in those with PEO, and multiple mtDNA deletions.
Authors Affiliations: Departamento de Bioquímica, Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM, Facultad de Medicina, Universidad Autónoma de Madrid (Mr González-Vioque and Drs Bornstein, Fernández-Moreno, and Garesse), Centro de Investigación, Hospital Universitario 12 de Octubre (Messrs Blázquez and Fernández-Moreira and Drs Campos, Arenas, and Martín), and Servicio de Neurología, Hospital Universitario La Paz (Dr Arpa), Madrid, Spain; Servicio de Neurología, Hospital Virgen del Rocío, Sevilla, Spain (Dr Bautista); Servicio de Anatomía Patológica, Hospital Do Meixoeiro, Vigo, Spain (Dr Navarro).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children
Stewart et al.
J. Med. Genet. 2009;46:209-214.
ABSTRACT
| FULL TEXT
Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations
Ashley et al.
Hum Mol Genet 2008;17:2496-2506.
ABSTRACT
| FULL TEXT
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes
Amati-Bonneau et al.
Brain 2008;131:338-351.
ABSTRACT
| FULL TEXT
Modulation of the W748S mutation in DNA polymerase {gamma} by the E1143G polymorphismin mitochondrial disorders
Chan et al.
Hum Mol Genet 2006;15:3473-3483.
ABSTRACT
| FULL TEXT
Phenotypic spectrum associated with mutations of the mitochondrial polymerase {gamma} gene
Horvath et al.
Brain 2006;129:1674-1684.
ABSTRACT
| FULL TEXT
|
